What they were paid
OnKure Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $0 | $0 | $0 | — | $0 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: OnKure Therapeutics, Inc. DEF 14A filed April 21, 2026, accession 0001140361-26-015903, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025OnKure Therapeutics pays directors a $40,000 cash retainer.
The rest of the OnKure Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Andrew Phillips, Ph.D | Independent Director | $103,794 |
| Dr. Saccomano | Director | $0 |
| Edward Mathers | Independent Director | $61,292 |
| Isaac Manke, Ph.D | Independent Director | $76,791 |
| Michael Grey | Independent Director | $56,294 |
| Nicholas Saccomano | Director | $0 |
| R. Michael Carruthers | Independent Director | $71,294 |
| Valerie M. Jansen, M.D., Ph.D | Independent Director | $60,294 |
The full OnKure Therapeutics compensation record
free company briefThis page is one director within OnKure Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat